MedTrace Logo

A Multi-center Retrospective Study of INO Treating B-ALL

NCT07238907 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-11-25

No results posted yet for this study

Summary

This multi-center retrospective study aims to evaluate the efficacy and safety of inotuzumab ozogamicin in adults B-ALL of different subgroups. This study is a retrospective study. Data will be collected from Electronic Medical Record, interventions will not be implemented on patients.

Conditions

  • Acute Lymphoblastic Leukaemia
  • Acute Lymphoblastic Leukaemias (ALL)
  • Inotuzumab Ozogamicin
  • Venetoclax

Interventions

DRUG

Inotuzumab Ozogamicin

All patients have received Inotuzumab Ozogamicin

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2025-06-30
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07238907 on ClinicalTrials.gov